Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tivic Health Systems (TIVC) Research & Development (2021 - 2025)

Historic Research & Development for Tivic Health Systems (TIVC) over the last 5 years, with Q3 2025 value amounting to $858000.0.

  • Tivic Health Systems' Research & Development rose 10331.75% to $858000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 6276.12%. This contributed to the annual value of $1.3 million for FY2024, which is 2066.47% down from last year.
  • As of Q3 2025, Tivic Health Systems' Research & Development stood at $858000.0, which was up 10331.75% from $655000.0 recorded in Q2 2025.
  • Tivic Health Systems' Research & Development's 5-year high stood at $858000.0 during Q3 2025, with a 5-year trough of $175000.0 in Q3 2021.
  • Its 5-year average for Research & Development is $390842.1, with a median of $360000.0 in 2023.
  • Its Research & Development has fluctuated over the past 5 years, first soared by 15885.42% in 2022, then tumbled by 4775.51% in 2024.
  • Tivic Health Systems' Research & Development (Quarter) stood at $313000.0 in 2021, then surged by 38.98% to $435000.0 in 2022, then dropped by 17.24% to $360000.0 in 2023, then fell by 7.5% to $333000.0 in 2024, then surged by 157.66% to $858000.0 in 2025.
  • Its Research & Development stands at $858000.0 for Q3 2025, versus $655000.0 for Q2 2025 and $335000.0 for Q1 2025.